RhumbLine Advisers’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Buy |
153,377
+4,883
| +3% | +$3.57K | ﹤0.01% | 3494 |
|
|
2025
Q1 | $120K | Sell |
148,494
-6,707
| -4% | -$5.41K | ﹤0.01% | 3326 |
|
|
2024
Q4 | $214K | Buy |
155,201
+5,692
| +4% | +$7.86K | ﹤0.01% | 3157 |
|
|
2024
Q3 | $155K | Sell |
149,509
-5,395
| -3% | -$5.61K | ﹤0.01% | 3346 |
|
|
2024
Q2 | $268K | Buy |
154,904
+25,241
| +19% | +$43.7K | ﹤0.01% | 3066 |
|
|
2024
Q1 | $310K | Buy |
129,663
+4,985
| +4% | +$11.9K | ﹤0.01% | 2963 |
|
|
2023
Q4 | $415K | Sell |
124,678
-2,998
| -2% | -$9.98K | ﹤0.01% | 2778 |
|
|
2023
Q3 | $477K | Sell |
127,676
-93,411
| -42% | -$349K | ﹤0.01% | 2637 |
|
|
2023
Q2 | $944K | Buy |
221,087
+15,314
| +7% | +$65.4K | ﹤0.01% | 2321 |
|
|
2023
Q1 | $1.41M | Buy |
205,773
+10,159
| +5% | +$69.5K | ﹤0.01% | 1986 |
|
|
2022
Q4 | $1.55M | Buy |
195,614
+8,508
| +5% | +$67.4K | ﹤0.01% | 1919 |
|
|
2022
Q3 | $1.8M | Buy |
187,106
+6,803
| +4% | +$65.4K | ﹤0.01% | 1820 |
|
|
2022
Q2 | $1.31M | Buy |
180,303
+15,203
| +9% | +$110K | ﹤0.01% | 2002 |
|
|
2022
Q1 | $2.13M | Buy |
165,100
+8,992
| +6% | +$116K | ﹤0.01% | 1788 |
|
|
2021
Q4 | $2.49M | Sell |
156,108
-1,640
| -1% | -$26.2K | ﹤0.01% | 1756 |
|
|
2021
Q3 | $2.54M | Sell |
157,748
-27,601
| -15% | -$444K | ﹤0.01% | 1760 |
|
|
2021
Q2 | $2.56M | Sell |
185,349
-2,818
| -1% | -$39K | ﹤0.01% | 1828 |
|
|
2021
Q1 | $2.75M | Buy |
188,167
+10,653
| +6% | +$156K | ﹤0.01% | 1752 |
|
|
2020
Q4 | $3.09M | Buy |
177,514
+7,144
| +4% | +$124K | ﹤0.01% | 1629 |
|
|
2020
Q3 | $3.13M | Sell |
170,370
-11,593
| -6% | -$213K | ﹤0.01% | 1435 |
|
|
2020
Q2 | $3.25M | Buy |
181,963
+79,478
| +78% | +$1.42M | 0.01% | 1451 |
|
|
2020
Q1 | $1.66M | Sell |
102,485
-3,473
| -3% | -$56.3K | ﹤0.01% | 1641 |
|
|
2019
Q4 | $1.91M | Buy |
105,958
+3,753
| +4% | +$67.6K | ﹤0.01% | 1815 |
|
|
2019
Q3 | $2.07M | Sell |
102,205
-3,956
| -4% | -$80.2K | ﹤0.01% | 1728 |
|
|
2019
Q2 | $2.35M | Buy |
106,161
+16,746
| +19% | +$370K | ﹤0.01% | 1642 |
|
|
2019
Q1 | $1.22M | Buy |
89,415
+21,164
| +31% | +$289K | ﹤0.01% | 1942 |
|
|
2018
Q4 | $618K | Buy |
68,251
+24,533
| +56% | +$222K | ﹤0.01% | 2199 |
|
|
2018
Q3 | $721K | Sell |
43,718
-1,363
| -3% | -$22.5K | ﹤0.01% | 2134 |
|
|
2018
Q2 | $631K | Buy |
45,081
+9,549
| +27% | +$134K | ﹤0.01% | 2211 |
|
|
2018
Q1 | $393K | Sell |
35,532
-665
| -2% | -$7.36K | ﹤0.01% | 2312 |
|
|
2017
Q4 | $319K | Sell |
36,197
-6,595
| -15% | -$58.1K | ﹤0.01% | 2441 |
|
|
2017
Q3 | $571K | Buy |
42,792
+510
| +1% | +$6.81K | ﹤0.01% | 2249 |
|
|
2017
Q2 | $607K | Buy |
42,282
+6,105
| +17% | +$87.6K | ﹤0.01% | 2201 |
|
|
2017
Q1 | $765K | Buy |
36,177
+3,969
| +12% | +$83.9K | ﹤0.01% | 2050 |
|
|
2016
Q4 | $907K | Buy |
32,208
+2,433
| +8% | +$68.5K | ﹤0.01% | 1908 |
|
|
2016
Q3 | $797K | Buy |
29,775
+1,180
| +4% | +$31.6K | ﹤0.01% | 1944 |
|
|
2016
Q2 | $483K | Buy |
28,595
+6,036
| +27% | +$102K | ﹤0.01% | 2216 |
|
|
2016
Q1 | $479K | Buy |
22,559
+105
| +0.5% | +$2.23K | ﹤0.01% | 2254 |
|
|
2015
Q4 | $516K | Buy |
22,454
+1,705
| +8% | +$39.2K | ﹤0.01% | 2220 |
|
|
2015
Q3 | $416K | Buy |
20,749
+864
| +4% | +$17.3K | ﹤0.01% | 2357 |
|
|
2015
Q2 | $575K | Buy |
+19,885
| New | +$575K | ﹤0.01% | 2233 |
|